MWM
IHE icon

Massachusetts Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Massachusetts Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Sell
14,625
-195
-1% -$17.6K 0.55% 65
2026
Q1 		$1.28M Sell
14,820
-410
-3% -$35.9K 0.56% 65
2025
Q4 		$1.29M Sell
15,230
-245
-2% -$19.6K 0.6% 63
2025
Q3 		$1.12M Sell
15,475
-245
-2% -$16.9K 0.56% 68
2025
Q2 		$1.03M Buy
15,720
+325
+2% +$21.2K 0.58% 66
2025
Q1 		$1.09M Buy
15,395
+935
+6% +$65K 0.74% 57
2024
Q4 		$950K Sell
14,460
-90
-0.6% -$6.19K 0.59% 68
2024
Q3 		$1.03M Sell
14,550
-285
-2% -$19.9K 0.65% 63
2024
Q2 		$984K Hold
14,835
– – 0.66% 59
2024
Q1 		$1.01M Sell
14,835
-150
-1% -$9.92K 0.71% 56
2023
Q4 		$926K Sell
14,985
-90
-0.6% -$5.29K 0.75% 54
2023
Q3 		$889K Sell
15,075
-750
-5% -$46K 0.82% 51
2023
Q2 		$945K Buy
15,825
+750
+5% +$44.6K 0.9% 48
2023
Q1 		$881K Sell
15,075
-915
-6% -$55.1K 0.91% 47
2022
Q4 		$989K Buy
+15,990
New +$962K 0.96% 47

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Massachusetts Wealth Management's IHE Position: Q2 2026 in Review

Massachusetts Wealth Management reduced its iShares US Pharmaceuticals ETF (IHE) stake by 1.3% in Q2 2026, selling an estimated $17.6K and leaving 14,625 shares worth $1.45M. The position accounts for 0.55% of the portfolio, ranked #65.

Massachusetts Wealth Management first reported a position in IHE in Q4 2022 and has held it in 15 quarters since. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Massachusetts Wealth Management held 14,625 shares of iShares US Pharmaceuticals ETF worth $1.45M as of Q2 2026.
  • Massachusetts Wealth Management sold 195 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $17.6K.
  • iShares US Pharmaceuticals ETF made up 0.55% of Massachusetts Wealth Management's portfolio in Q2 2026, its #65 holding.
  • Massachusetts Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2022 and has held it in 15 quarters since.
  • 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Massachusetts Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.